Literature DB >> 34657964

Colorimetric paper-based sarcosine assay with improved sensitivity.

Sera Ohta1, Misaki Nakagawa1, Mayu Masumoto1, Yuki Hiruta1, Daniel Citterio2.   

Abstract

This manuscript reports on a simple paper-based bienzymatic colorimetric assay for sarcosine as an important urinary biomarker of prostate cancer. All required assay reagents are pre-deposited on hydrophilic filter paper spots surrounded by a hydrophobic barrier. Sarcosine in the sample solution is selectively oxidized in the presence of sarcosine oxidase (SOx), resulting in the formation of hydrogen peroxide, which is subsequently detected through the horseradish peroxidase (HRP)-catalyzed conversion of the colorless indicator 3,3',5,5'-tetramethylbenzidine (TMB) into its blue-colored oxidation product. By the modification of the paper with positively charged poly(allylamine hydrochloride) (PAH), a linear response to sarcosine between 0 and 10 μM and a significant lowering of the limit of detection (LOD) (0.6 μM) compared to the unmodified paper substrate (12.6 μM) has been achieved. The improvement of the LOD was attributed to the fact that the presence of the polymer limits the enzyme-driven colorimetric reaction to the surface of the paper substrate, resulting in stronger color development. In experiments in artificial urine matrix, the bicarbonate anion was identified as an inhibitor of the colorimetric reaction. This inhibition was successfully eliminated through on-device sample pH adjustments with pH-buffer components pre-deposited onto assay devices. The LOD for sarcosine achieved in artificial urine matrix (2.5 μM) is below the 5 μM threshold value for this urinary biomarker required for diagnostic purposes. Finally, good selectivity over all 20 natural amino acids and satisfactory long-term storage stability of reagent-modified paper substrates at - 20 °C for a period of 50 days were confirmed.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Artificial urine; Cationically charged polyamine; Enzymatic sarcosine assay; Hydrogen peroxide; Prostate cancer biomarker; Sarcosine oxidase

Mesh:

Substances:

Year:  2021        PMID: 34657964     DOI: 10.1007/s00216-021-03682-0

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  32 in total

1.  Quantitative determination of sarcosine and related compounds in urinary samples by liquid chromatography with tandem mass spectrometry.

Authors:  Yongqing Jiang; Xiaoliang Cheng; Chuan Wang; Yinfa Ma
Journal:  Anal Chem       Date:  2010-10-12       Impact factor: 6.986

2.  Biomarkers. Metabolite in urine may point to high-risk prostate cancer.

Authors:  Jennifer Couzin
Journal:  Science       Date:  2009-02-13       Impact factor: 47.728

3.  Colorimetric determination of sarcosine in urine samples of prostatic carcinoma by mimic enzyme palladium nanoparticles.

Authors:  Jianming Lan; Wenming Xu; Qiping Wan; Xi Zhang; Jia Lin; Jinghua Chen; Jianzhong Chen
Journal:  Anal Chim Acta       Date:  2014-03-31       Impact factor: 6.558

4.  Gene to diagnostic: Self immobilizing protein for silica microparticle biosensor, modelled with sarcosine oxidase.

Authors:  Cassi J Henderson; Elizabeth Pumford; Dushanth J Seevaratnam; Ronan Daly; Elizabeth A H Hall
Journal:  Biomaterials       Date:  2018-12-08       Impact factor: 12.479

Review 5.  Toward practical application of paper-based microfluidics for medical diagnostics: state-of-the-art and challenges.

Authors:  Kentaro Yamada; Hiroyuki Shibata; Koji Suzuki; Daniel Citterio
Journal:  Lab Chip       Date:  2017-03-29       Impact factor: 6.799

Review 6.  CE: early localized prostate cancer.

Authors:  Anne Katz
Journal:  Am J Nurs       Date:  2015-03       Impact factor: 2.220

7.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Authors:  Arun Sreekumar; Laila M Poisson; Thekkelnaycke M Rajendiran; Amjad P Khan; Qi Cao; Jindan Yu; Bharathi Laxman; Rohit Mehra; Robert J Lonigro; Yong Li; Mukesh K Nyati; Aarif Ahsan; Shanker Kalyana-Sundaram; Bo Han; Xuhong Cao; Jaeman Byun; Gilbert S Omenn; Debashis Ghosh; Subramaniam Pennathur; Danny C Alexander; Alvin Berger; Jeffrey R Shuster; John T Wei; Sooryanarayana Varambally; Christopher Beecher; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

Review 8.  Biomarkers for prostate cancer.

Authors:  Eric Schiffer
Journal:  World J Urol       Date:  2007-08-10       Impact factor: 4.226

9.  Paramagnetic nanoparticles as a platform for FRET-based sarcosine picomolar detection.

Authors:  Zbynek Heger; Natalia Cernei; Sona Krizkova; Michal Masarik; Pavel Kopel; Petr Hodek; Ondrej Zitka; Vojtech Adam; Rene Kizek
Journal:  Sci Rep       Date:  2015-03-09       Impact factor: 4.379

Review 10.  Prostate Cancer in Primary Care.

Authors:  Samuel W D Merriel; Garth Funston; Willie Hamilton
Journal:  Adv Ther       Date:  2018-08-10       Impact factor: 3.845

View more
  1 in total

Review 1.  Colorimetric Paper-Based Sensors against Cancer Biomarkers.

Authors:  Mariana C C G Carneiro; Ligia R Rodrigues; Felismina T C Moreira; Maria Goreti F Sales
Journal:  Sensors (Basel)       Date:  2022-04-22       Impact factor: 3.847

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.